TB-500 provides critical enhancement of cellular migration and epithelial coverage that drives wound closure, with research demonstrating that topical or intraperitoneal TB-500 administration increases reepithelialization by 42% over controls at 4 days post-wounding and 61% at 7 days, with treated wounds showing enhanced contraction (at least 11% more than controls by day 7) and superior architectural organization
It should only be handled by qualified laboratory professionals and must not be misrepresented, misused, or mislabeled as a drug, food, cosmetic, or medical device
doi:10.1016/j.aju.2017.12.004
Timing and Frequency Considerations: AOD-9604 is most commonly administered once daily in the morning on an empty stomach to maximize absorption and align with natural circadian metabolic rhythms
It is the most beautiful setting, tucked into a wooden valley in Roundwood with such a peaceful Mountain setting, Deerstone is the perfect escape to reset your energy and take such precious time away from it all
